In Search of Ideal Solutions for Cancer Diagnosis: From Conventional Methods to Protein Biomarkers in Liquid Biopsy
Proteomes · 23.09.2025 · 13 (4) · 47
DOI: 10.3390/proteomes13040047 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Proteomes, online erschienen am 23.09.2025. Verfasst von Anca-Narcisa Neagu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Animal Histology, Faculty of Biology, "Alexandru Ioan Cuza" University of Iași, Carol I bvd. 20A, 700505 Iasi, Romania. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 266 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute of the National Institutes of Health, “Al. I. Cuza” University of Iasi, Romania.
Abstract (Originalsprache)
Cancer detection has made significant progress, moving from conventional methods to innovative, non-invasive or minimally invasive approaches aimed at improving early diagnosis, precision, and treatment outcomes. This review examines current and emerging diagnostic technologies, including liquid biopsy (LB), molecular biomarkers, and artificial intelligence (AI). LB analyzes biomarkers in bodily fluids, showing promise in detecting tumors at molecular levels, monitoring cancer progression, and predicting treatment responses. The assignment of specific proteoforms, often linked to tumor subtype, stage, and therapy resistance, adds another layer of diagnostic precision, offering valuable insights for personalized oncology. However, the clinical application of LB faces challenges related to sensitivity, specificity, tumor heterogeneity, and a lack of standardized protocols. Relatively high costs, complex result interpretation, and privacy concerns also hinder its widespread adoption in clinical practice. Despite these challenges, advancements in AI, nanotechnology, and multi-omics strategies offer opportunities to enhance cancer diagnostic accuracy. Future developments, including wearable biosensors and lab-on-a-chip technologies, could lead to personalized, real-time cancer detection with improved patient outcomes, potentially redefining cancer care and fostering a more proactive, patient-centered healthcare approach.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Animal Histology, Faculty of Biology, "Alexandru Ioan Cuza" University of Iași, Carol I bvd. 20A, 700505 Iasi, Romania.
- Biochemistry & Proteomics Laboratories, Department of Chemistry and Biochemistry, Clarkson University, Potsdam, NY 13699-5810, USA.
ORCID-Profile: Victor T Njoku, Costel C Darie
Förderung
- NCI NIH HHS
- National Cancer Institute of the National Institutes of Health
- “Al. I. Cuza” University of Iasi, Romania
Zitieren
APA
Neagu, A. N., Bruno, P. S., Josan, C. L., Waterman, N., Morrissiey, H., Njoku, V. T., & Darie, C. C. (2025). In Search of Ideal Solutions for Cancer Diagnosis: From Conventional Methods to Protein Biomarkers in Liquid Biopsy. Proteomes, 13(4), 47. https://doi.org/10.3390/proteomes13040047
Vancouver
Neagu AN, Bruno PS, Josan CL, Waterman N, Morrissiey H, Njoku VT, et al. In Search of Ideal Solutions for Cancer Diagnosis: From Conventional Methods to Protein Biomarkers in Liquid Biopsy. Proteomes. 2025;13(4):47. doi:10.3390/proteomes13040047
BibTeX
@article{Neagu2025,
author = {Neagu, Anca-Narcisa and Bruno, Pathea S and Josan, Claudiu-Laurentiu and Waterman, Natalie and Morrissiey, Hailey and Njoku, Victor T and Darie, Costel C},
title = {In Search of Ideal Solutions for Cancer Diagnosis: From Conventional Methods to Protein Biomarkers in Liquid Biopsy},
journal = {Proteomes},
year = {2025},
volume = {13},
number = {4},
pages = {47},
doi = {10.3390/proteomes13040047}
}
EUVIMED